Publications:

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.

Plos One

Hamann, Martin V MV; Beschorner, Niklas N; Vu, Xuan-Khang XK; Hauber, Ilona I; Lange, Ulrike C UC; Traenkle, Bjoern B; Kaiser, Philipp D PD; Foth, Daniel D; Schneider, Carola C; Büning, Hildegard H; Rothbauer, Ulrich U; Hauber, Joachim J

Publication Date: 2021

Variant appearance in text: CCD: Y444F

PubMed Link: 34928979

Variant Present in the following documents:

• Main text
• pone.0261269.pdf

View BVdb publication page

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.

Plos One

Hamann, Martin V MV; Beschorner, Niklas N; Vu, Xuan-Khang XK; Hauber, Ilona I; Lange, Ulrike C UC; Traenkle, Bjoern B; Kaiser, Philipp D PD; Foth, Daniel D; Schneider, Carola C; Büning, Hildegard H; Rothbauer, Ulrich U; Hauber, Joachim J

Publication Date: 2021

Variant appearance in text: CCD: Y444F

PubMed Link: 34928979

Variant Present in the following documents:

• Main text
• pone.0261269.pdf

View BVdb publication page

PTEN knockdown with the Y444F mutant AAV2 vector promotes axonal regeneration in the adult optic nerve.

Neural Regeneration Research

Huang, Zheng-Ru ZR; Chen, Hai-Ying HY; Hu, Zi-Zhong ZZ; Xie, Ping P; Liu, Qing-Huai QH

Publication Date: 2018-01

Variant appearance in text: CCD: Y444F

PubMed Link: 29451218

Variant Present in the following documents:

• Main text
• NRR-13-135.pdf

View BVdb publication page

Tyrosine-mutated AAV2-mediated shRNA silencing of PTEN promotes axon regeneration of adult optic nerve.

Plos One

Huang, ZhengRu Z; Hu, ZiZhong Z; Xie, Ping P; Liu, QingHuai Q

Publication Date: 2017

Variant appearance in text: CCD: Y444F

PubMed Link: 28323869

Variant Present in the following documents:

• Main text
• pone.0174096.pdf

View BVdb publication page